| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Analysis of Plasmodium falciparum diversity in natural infections by deep sequencing.
|
Nature
|
2012
|
4.37
|
|
2
|
Multiple origins and regional dispersal of resistant dhps in African Plasmodium falciparum malaria.
|
PLoS Med
|
2009
|
3.38
|
|
3
|
The origins and spread of antimalarial drug resistance: lessons for policy makers.
|
Acta Trop
|
2005
|
2.64
|
|
4
|
Molecular determination of point mutation haplotypes in the dihydrofolate reductase and dihydropteroate synthase of Plasmodium falciparum in three districts of northern Tanzania.
|
Antimicrob Agents Chemother
|
2003
|
2.57
|
|
5
|
Intermittent preventive therapy for malaria during pregnancy using 2 vs 3 or more doses of sulfadoxine-pyrimethamine and risk of low birth weight in Africa: systematic review and meta-analysis.
|
JAMA
|
2013
|
2.51
|
|
6
|
World Antimalarial Resistance Network (WARN) III: molecular markers for drug resistant malaria.
|
Malar J
|
2007
|
2.30
|
|
7
|
High resistance of Plasmodium falciparum to sulphadoxine/pyrimethamine in northern Tanzania and the emergence of dhps resistance mutation at Codon 581.
|
PLoS One
|
2009
|
2.18
|
|
8
|
Increased gametocytemia after treatment: an early parasitological indicator of emerging sulfadoxine-pyrimethamine resistance in falciparum malaria.
|
J Infect Dis
|
2008
|
1.96
|
|
9
|
The transit phase of migration: circulation of malaria and its multidrug-resistant forms in Africa.
|
PLoS Med
|
2011
|
1.78
|
|
10
|
Emergence of a dhfr mutation conferring high-level drug resistance in Plasmodium falciparum populations from southwest Uganda.
|
J Infect Dis
|
2008
|
1.73
|
|
11
|
Association of sub-microscopic malaria parasite carriage with transmission intensity in north-eastern Tanzania.
|
Malar J
|
2011
|
1.63
|
|
12
|
Mapping 'partially resistant', 'fully resistant', and 'super resistant' malaria.
|
Trends Parasitol
|
2013
|
1.61
|
|
13
|
A simple, high-throughput method to detect Plasmodium falciparum single nucleotide polymorphisms in the dihydrofolate reductase, dihydropteroate synthase, and P. falciparum chloroquine resistance transporter genes using polymerase chain reaction- and enzyme-linked immunosorbent assay-based technology.
|
Am J Trop Med Hyg
|
2005
|
1.56
|
|
14
|
Following the path of most resistance: dhps K540E dispersal in African Plasmodium falciparum.
|
Trends Parasitol
|
2010
|
1.53
|
|
15
|
Mitigating the threat of artemisinin resistance in Africa: improvement of drug-resistance surveillance and response systems.
|
Lancet Infect Dis
|
2012
|
1.53
|
|
16
|
Reduced variation around drug-resistant dhfr alleles in African Plasmodium falciparum.
|
Mol Biol Evol
|
2005
|
1.36
|
|
17
|
Drug resistance maps to guide intermittent preventive treatment of malaria in African infants.
|
Parasitology
|
2011
|
1.28
|
|
18
|
Associations between alpha+-thalassemia and Plasmodium falciparum malarial infection in northeastern Tanzania.
|
J Infect Dis
|
2007
|
1.25
|
|
19
|
Monitoring for multidrug-resistant Plasmodium falciparum isolates and analysis of pyrimethamine resistance evolution in Uige province, Angola.
|
Trop Med Int Health
|
2009
|
1.19
|
|
20
|
Drug coverage in treatment of malaria and the consequences for resistance evolution--evidence from the use of sulphadoxine/pyrimethamine.
|
Malar J
|
2010
|
1.19
|
|
21
|
Spatiotemporal mathematical modelling of mutations of the dhps gene in African Plasmodium falciparum.
|
Malar J
|
2013
|
1.11
|
|
22
|
Efficacy of antimalarial treatment in Guinea: in vivo study of two artemisinin combination therapies in Dabola and molecular markers of resistance to sulphadoxine-pyrimethamine in N'Zérékoré.
|
Malar J
|
2007
|
1.10
|
|
23
|
Protective efficacy of intermittent preventive treatment of malaria in infants (IPTi) using sulfadoxine-pyrimethamine and parasite resistance.
|
PLoS One
|
2010
|
1.04
|
|
24
|
Five years of large-scale dhfr and dhps mutation surveillance following the phased implementation of artesunate plus sulfadoxine-pyrimethamine in Maputo Province, Southern Mozambique.
|
Am J Trop Med Hyg
|
2010
|
1.03
|
|
25
|
Differential effect of regional drug pressure on dihydrofolate reductase and dihydropteroate synthetase mutations in southern Mozambique.
|
Am J Trop Med Hyg
|
2008
|
1.03
|
|
26
|
Efficacy of amodiaquine, sulphadoxine-pyrimethamine and their combination for the treatment of uncomplicated Plasmodium falciparum malaria in children in Cameroon at the time of policy change to artemisinin-based combination therapy.
|
Malar J
|
2010
|
1.02
|
|
27
|
Sustained use of insecticide-treated curtains is not associated with greater circulation of drug-resistant malaria parasites, or with higher risk of treatment failure among children with uncomplicated malaria in Burkina Faso.
|
Am J Trop Med Hyg
|
2007
|
0.99
|
|
28
|
The effect of dosing strategies on the therapeutic efficacy of artesunate-amodiaquine for uncomplicated malaria: a meta-analysis of individual patient data.
|
BMC Med
|
2015
|
0.99
|
|
29
|
PlasmoView: a web-based resource to visualise global Plasmodium falciparum genomic variation.
|
J Infect Dis
|
2013
|
0.97
|
|
30
|
High prevalence of dhfr triple mutant and correlation with high rates of sulphadoxine-pyrimethamine treatment failures in vivo in Gabonese children.
|
Malar J
|
2011
|
0.96
|
|
31
|
Origin and dissemination across the Colombian Andes mountain range of sulfadoxine-pyrimethamine resistance in Plasmodium falciparum.
|
Antimicrob Agents Chemother
|
2010
|
0.96
|
|
32
|
Trends in chloroquine resistance marker, Pfcrt-K76T mutation ten years after chloroquine withdrawal in Tanzania.
|
Malar J
|
2013
|
0.95
|
|
33
|
Modelling the impact of intermittent preventive treatment for malaria on selection pressure for drug resistance.
|
Malar J
|
2007
|
0.95
|
|
34
|
Independent origin of plasmodium falciparum antifolate super-resistance, Uganda, Tanzania, and Ethiopia.
|
Emerg Infect Dis
|
2014
|
0.95
|
|
35
|
Association between recent internal travel and malaria in Ugandan highland and highland fringe areas.
|
Trop Med Int Health
|
2015
|
0.87
|
|
36
|
Analysis of polymorphisms in the merozoite surface protein-3α gene and two microsatellite loci in Sri Lankan Plasmodium vivax: evidence of population substructure in Sri Lanka.
|
Am J Trop Med Hyg
|
2011
|
0.87
|
|
37
|
The evolution of pyrimethamine resistant dhfr in Plasmodium falciparum of south-eastern Tanzania: comparing selection under SP alone vs SP+artesunate combination.
|
Malar J
|
2011
|
0.86
|
|
38
|
Monitoring antifolate resistance in intermittent preventive therapy for malaria.
|
Trends Parasitol
|
2013
|
0.86
|
|
39
|
Surveillance of artemether-lumefantrine associated Plasmodium falciparum multidrug resistance protein-1 gene polymorphisms in Tanzania.
|
Malar J
|
2014
|
0.85
|
|
40
|
A community-randomized evaluation of the effect of intermittent preventive treatment in infants on antimalarial drug resistance in southern Tanzania.
|
J Infect Dis
|
2012
|
0.83
|
|
41
|
Evolutionary genetics: microarrays and species origins.
|
Nature
|
2005
|
0.82
|
|
42
|
Malaria genomics meets drug-resistance phenotyping in the field.
|
Genome Biol
|
2009
|
0.79
|
|
43
|
Media, health workers, and policy makers' relationship and their impact on antimalarial policy adoption: a population genetics perspective.
|
Malar Res Treat
|
2011
|
0.77
|
|
44
|
Surveillance of travellers: an additional tool for tracking antimalarial drug resistance in endemic countries.
|
PLoS One
|
2013
|
0.77
|
|
45
|
The polymorphic linker domain of pfmdr1 is associated with resistance-conferring mutations in Plasmodium falciparum populations from East and West Africa.
|
Antimicrob Agents Chemother
|
2013
|
0.76
|